IVF after COVID-19: ASRM and SART Release Reopening Guidelines

[This article deals with a continuously developing situation. It was written by Norbert Gleicher, MD, on April 28, 2020 and published on April 29, 2020. For a list of all COVID-19 Bulletins, scroll to the bottom.] 

We are very pleased that the American Society for Reproductive Medicine (ASRM) and its daughter society, the Society for Assisted Reproductive Technology (SART) on April 24 published new guidance for fertility centers that closed their doors during the COVID-19 crisis and, now, are considering resuming patient care. CHR sees this as an important first step in reopening the infrastructure many couples and individuals urgently need in order to be able to access fertility services. We also hope that reopening of some IVF centers will ease the burden on the centers that are still open but have started to refuse monitoring for outside patients due to being “too busy.”

Availability of PPE will be just one part of the reopening considerations for IVF centers that closed to prevent the spread of COVID-19. Image by Jon Tyson via Unsplash.

Since CHR never closed its doors, most of the recommendations made in this guidance have already been implemented. Some policies that have been in place at CHR over the last few weeks even exceeded measures recommended by ASRM/SART. The guidance, however, also proposed new language for an informed consent for as long as risks of COVID-19 infections persists, and CHR will implement this consent starting this week. We are looking forward to serving our patients in the safest and most effective ways, as we have done over the last few weeks. We are hopeful that we will be able to progressively relax some of the currently still in place restrictions over the coming weeks and months. Please do not hesitate to contact us with any questions you may have, at 212-994-4400 or online.

CHR’s COVID-19 Bulletins

  1. News you, likely, will not find in the media (Published on July 6, 2020)
  2. Notable reports in medical literature and the media on COVID-19 and immunity against it (Published on July 6, 2020)
  3. COVID-19 cases rapidly increase in South and Western U.S. states but that will help build herd immunity (Published on June 29, 2020)
  4. Are we witnessing a second wave of COVID-19 outbreak? (Published on June 22, 2020)
  5. WHO was wrong about asymptomatic patients being contagious & other COVID-19 fake news (Published on June 10, 2020)
  6. Updated COVID-19 precautions at CHR (Published on June 9, 2020)
  7. What we now know about COVID-19 and what it means for mitigation strategies (Published on May 22, 2020)
  8. COVID-19 response in retrospect, as well as going forward (Published on May 7, 2020)
  9. The essence of the COVID-19 pandemic (Published on May 7, 2020)
  10. Practical consequences of COVID-19 for CHR’s fertility patients (Published May 7, 2020)
  11. IVF after COVID-19: ASRM and SART release reopening guidelines for IVF centers (Published on 4/29/2020)
  12. One medical expert, missing from all COVID-19 task forces, who should be listened to (Published on 4/29/2020)
  13. Governments worldwide should have let herd immunity develop rather than cause one of the worst recessions on wild guesses of “experts” (Published 4/27/2020)
  14. Reciprocal collaboration among IVF centers for cycle monitoring may be on the wane (Published 4/22/2020)
  15. Is embryo freezing better than IVF during COVID-19 outbreak? (Published on 4/17/2020)
  16. When to restart fertility treatments after COVID-19 (Published on 4/17/2020)
  17. “Reopening” of fertility centers after COVID-19: How that may look like (Published on 4/17/2020)
  18. Some IVF centers may never reopen (Published on 4/17/2020)
  19. Skepticism warranted for “expert opinions” on COVID-19 (Published on 4/13/2020)
  20. Fertility Providers’ Alliance tries to reframe ASRM’s reaffirmation of COVID-19 guidelines as FPA victory (Published on 4/6/2020)
  21. States in the Northeast may see first signs of “flattening the curve” (Published on 4/6/2020)
  22. Reported death rate exaggerated by the media, shelter in place or herd immunity, first COVID-19 antibody test approved, and more (Published on 4/3/2020)
  23. What can I do to continue on my fertility journey? [VIDEO] (Filmed on 3/26/2020, published on 4/2/2020)
  24. “Controversy” over ASRM recommendation hints at investor interest’s power grab amid COVID-19 pandemic (Published on 4/2/2020)
  25. Pregnant women concerned over delivery and babies during COVID-19 pandemic (Published 4/1/2020)
  26. ASRM’s COVID-19 Task Force reaffirms previous recommendations (Published 4/1/2020)
  27. To stay open or not: IVF centers argue over ASRM guidelines on COVID-19 and fertility treatments (Published 3/27/2020)
  28. Concerning news on COVID-19’s effects on pregnancy and newborn (Published 3/27/2020)
  29. What’s urgent is urgent and what’s not urgent isn’t: Explaining ASRM recommendations on fertility treatments during COVID-19 pandemic (Published 3/26/2020)
  30. Patient autonomy and “do no harm” principles mean CHR continues to offer fertility diagnosis and treatments during COVID-19 crisis (Published 3/23/2020)
  31. ASRM and SART’s recommendations on fertility treatment during COVID-19 outbreak (Published 3/18/2020)
  32. CHR’s response to the COVID-19 outbreak: What we are doing to protect our patients, staff and community (Published 3/13/2020)
  33. Does COVID-19 have an effect on fertility? (Published 3/13/2020) 
  34. What happens if I get quarantined during an IVF cycle? (Published 3/13/2020)
  35. What happens if CHR is closed for quarantine during my IVF cycle? (Published 3/13/2020) 
  36. What should fertility patients do during the coronavirus outbreak? (Published 3/13/2020) 
  37. Should international patients of IVF do anything differently during the outbreak? (Published 3/13/2020) 

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.